NCT07793591

Brief Summary

This study will study if medically tailored meals can improve health and well-being among Veterans with kidney disease. Participants will be randomly assigned to receive either medically tailored meals or usual care (wait-list control) for 3 months, followed by follow-up/crossover period. The study will evaluate blood pressure, kidney health, diet, quality of life, and other health outcomes, as well as the feasibility and acceptability of providing medically tailored meals to Veterans with kidney disease.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
36mo left

Started Oct 2027

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 18, 2026

Completed
10 days until next milestone

First Posted

Study publicly available on registry

August 28, 2026

Completed
1.1 years until next milestone

Study Start

First participant enrolled

October 1, 2027

Expected
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2030

3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2030

Last Updated

August 28, 2026

Status Verified

August 1, 2026

Enrollment Period

2.7 years

First QC Date

August 18, 2026

Last Update Submit

August 26, 2026

Conditions

Keywords

medically tailored mealschronic kidney diseasehypertensionnutritiondietVeterans

Outcome Measures

Primary Outcomes (1)

  • Systolic blood pressure (SBP)

    Change in systolic blood pressure (SBP), measured in mmHg, from baseline to the 3-month assessment.

    3 months

Secondary Outcomes (2)

  • Urine albumin-to-creatinine ratio (UACR)

    3 months

  • Estimated glomerular filtration rate (eGFR)

    3 months

Other Outcomes (3)

  • Diet quality and intake

    3 months, 6 months

  • Kidney Disease-Related Quality of Life

    3 months, 6 months

  • Medically Tailored Meal Adherence

    3 months, 6 months

Study Arms (2)

Medically tailored meals

EXPERIMENTAL

Participants randomized to this arm will receive medically tailored meals for 3 months in addition to usual clinical care. Meals will be designed to support dietary recommendations for chronic kidney disease, kidney and cardiovascular health. Participants will also receive nutrition education and study-related dietary support.

Other: Medically tailored meals (MTMs)

Wait-list control

OTHER

Participants randomized to this arm will continue usual clinical care without study-provided medically tailored meals during the initial 3-month randomized period. After completing the 3-month assessment, participants will cross over to receive the medically tailored meals intervention for 3 months.

Other: Medically tailored meals (MTMs)

Interventions

Medically tailored meals are prepared to support dietary recommendations for chronic kidney disease and cardiovascular health while considering individual dietary needs and preferences. The intervention also included nutrition education and study-related dietary support.

Also known as: MTM
Medically tailored mealsWait-list control

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Veteran enrolled in the Veterans Health Administration
  • Stage 3b or stage 4 Chronic Kidney Disease (CKD) ((estimated glomerular filtration rate (eGFR) 15-44 milliliter (mL)/minute/1.73 square meter (m²))
  • Systolic blood pressure 140-160 mmHg (millimeters of mercury); with a ± 5 mmHg tolerance range
  • Body mass index (BMI) between 18.5 and 40.0 kilogram (kg)/square meter (m²)
  • Able and willing to provide informed consent
  • Able and willing to participate in study visits and study procedures
  • Able to receive medically tailored meal deliveries within the study service area

You may not qualify if:

  • Inability to communicate in English or severe hearing impairment either, preventing study participation
  • Participation in a medically tailored meal program within the previous 6 months
  • Diagnosis of heart failure
  • Major active gastrointestinal disorder that would interfere with participation or nutritional management
  • Active cancer treatment (chemotherapy) or anticipated treatment within the next 12 months
  • Pregnancy
  • Current homelessness preventing meal delivery
  • Active substance use disorder not in remission
  • Active psychosis or another condition that would impair participation
  • Terminal illness or life expectancy less than 12 months
  • Any other medical, psychiatric, or social condition that, in the opinion of the investigators, would make participation unsafe or interfere with completion of the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rocky Mountain Regional VA Medical Center, Aurora, CO

Aurora, Colorado, 80045-7211, United States

Location

MeSH Terms

Conditions

Renal Insufficiency, ChronicHypertension

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsVascular DiseasesCardiovascular Diseases

Study Officials

  • Luis M Perez, PhD RD

    Rocky Mountain Regional VA Medical Center, Aurora, CO

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Luis M Perez, PhD RD

CONTACT

Maryam I Nuriyeva, MPH

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Clinical outcome assessments will be conducted by study personnel who are masked to participant treatment assignment when feasible. Participants and intervention personnel will not be masked due to the nature of the dietary intervention.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomized 1:1 to the medically tailored meal intervention or wait-list control group and followed in parallel.
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 18, 2026

First Posted

August 28, 2026

Study Start (Estimated)

October 1, 2027

Primary Completion (Estimated)

May 31, 2030

Study Completion (Estimated)

August 31, 2030

Last Updated

August 28, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

Locations